Universal Beteiligungs und Servicegesellschaft mbH Acquires Shares of 52,559 Solventum Co. (NYSE:SOLV)

Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Solventum Co. (NYSE:SOLV - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 52,559 shares of the company's stock, valued at approximately $3,472,000.

Several other institutional investors have also made changes to their positions in SOLV. New York Life Investment Management LLC raised its position in Solventum by 0.7% during the fourth quarter. New York Life Investment Management LLC now owns 18,506 shares of the company's stock valued at $1,223,000 after acquiring an additional 136 shares in the last quarter. EP Wealth Advisors LLC boosted its holdings in Solventum by 3.6% during the fourth quarter. EP Wealth Advisors LLC now owns 5,272 shares of the company's stock valued at $348,000 after acquiring an additional 181 shares during the period. Avantax Advisory Services Inc. grew its holdings in Solventum by 2.2% in the 4th quarter. Avantax Advisory Services Inc. now owns 8,835 shares of the company's stock valued at $584,000 after buying an additional 192 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in Solventum by 48.1% during the fourth quarter. EverSource Wealth Advisors LLC now owns 687 shares of the company's stock worth $45,000 after acquiring an additional 223 shares during the period. Finally, Savant Capital LLC increased its holdings in shares of Solventum by 6.3% during the 4th quarter. Savant Capital LLC now owns 3,914 shares of the company's stock worth $259,000 after purchasing an additional 233 shares during the period.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on SOLV shares. Wells Fargo & Company lifted their price objective on Solventum from $73.00 to $75.00 and gave the stock an "equal weight" rating in a report on Friday, February 28th. Mizuho raised their price target on shares of Solventum from $70.00 to $82.00 and gave the stock a "neutral" rating in a research note on Monday, March 3rd. Piper Sandler upgraded Solventum from a "neutral" rating to an "overweight" rating and upped their price objective for the company from $78.00 to $87.00 in a research note on Monday, May 19th. Bank of America increased their target price on Solventum from $80.00 to $85.00 and gave the stock a "neutral" rating in a report on Wednesday, February 26th. Finally, Morgan Stanley boosted their price target on Solventum from $73.00 to $80.00 and gave the company an "equal weight" rating in a research note on Wednesday, March 5th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, Solventum currently has an average rating of "Hold" and an average target price of $80.29.

Solventum Price Performance

SOLV stock traded up $1.11 during midday trading on Tuesday, reaching $74.23. 1,135,793 shares of the company's stock traded hands, compared to its average volume of 1,225,359. The company has a 50-day simple moving average of $69.42 and a two-hundred day simple moving average of $71.36. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. Solventum Co. has a 1-year low of $47.16 and a 1-year high of $85.92. The company has a market cap of $12.84 billion and a price-to-earnings ratio of 34.37.

Solventum (NYSE:SOLV - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $1.34 earnings per share for the quarter, beating analysts' consensus estimates of $1.19 by $0.15. The business had revenue of $2.07 billion during the quarter, compared to analyst estimates of $2.02 billion. The business's quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter last year, the business posted $2.08 earnings per share. On average, analysts anticipate that Solventum Co. will post 6.58 earnings per share for the current year.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.